Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.
Authors | |
Keywords | |
Abstract | Genome-scale expression studies and comprehensive loss-of-function genetic screens have focused almost exclusively on the highest confidence candidate genes. Here, we describe a strategy for characterizing the lower confidence candidates identified by such approaches. We interrogated 177 genes that we classified as essential for the proliferation of cancer cells exhibiting constitutive β-catenin activity and integrated data for each of the candidates, derived from orthogonal short hairpin RNA (shRNA) knockdown and clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9-mediated gene editing knockout screens, to yield 69 validated genes. We then characterized the relationships between sets of these genes using complementary assays: medium-throughput stable isotope labeling by amino acids in cell culture (SILAC)-based mass spectrometry, yielding 3,639 protein-protein interactions, and a CRISPR-mediated pairwise double knockout screen, yielding 375 combinations exhibiting greater- or lesser-than-additive phenotypic effects indicating genetic interactions. These studies identify previously unreported regulators of β-catenin, define functional networks required for the survival of β-catenin-active cancers, and provide an experimental strategy that may be applied to define other signaling networks. |
Year of Publication | 2016
|
Journal | Cell Syst
|
Volume | 3
|
Issue | 3
|
Pages | 302-316.e4
|
Date Published | 2016 09 28
|
ISSN | 2405-4712
|
DOI | 10.1016/j.cels.2016.09.001
|
PubMed ID | 27684187
|
PubMed Central ID | PMC5455996
|
Links | |
Grant list | U01 CA199253 / CA / NCI NIH HHS / United States
U24 CA194107 / CA / NCI NIH HHS / United States
U01 CA176058 / CA / NCI NIH HHS / United States
R01 CA154480 / CA / NCI NIH HHS / United States
R01 CA121941 / CA / NCI NIH HHS / United States
P50 CA127003 / CA / NCI NIH HHS / United States
R01 MH109903 / MH / NIMH NIH HHS / United States
|